P53 Mutants, DNA Medicine, and Mobile Genetic Elements

Register Link:

https://www.eventbrite.com/e/genobiotx-april-2025-webinar-tickets-1310558388419?aff=oddtdtcreator

Date:

  • Wednesday, April 23rd, 2025; 2:00 pm EDT or 11:00 am PDT

Meet Our Speaker:

Dr. Li earned his Ph.D. in Molecular Biology in 1999 from the Shanghai Institute of Biochemistry, Chinese Academy of Sciences, followed by postdoctoral training at Yale University (1999–2004). With over 20 years of experience in cancer molecular biology, Dr. Li has held faculty positions at the University of Louisville, Cleveland Clinic, and currently at Baylor College of Medicine, where he is also a CPRIT Scholar and a member of the Dan L Duncan Comprehensive Cancer Center.

A Fellow of the American Association for the Advancement of Science (AAAS), Dr. Li has authored over 210 peer-reviewed publications and received numerous honors, including the Achievement Award from the Society of American Asian Scientists in Cancer Research. His research focuses on tumor suppressor p53, mutant-specific cancer immunotherapies, DNA-encoded antibodies and vaccines, and environmental carcinogenesis. Dr. Li leads national and international collaborations aimed at developing novel strategies for cancer prevention and treatment.

About GenoBioTX

GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.

Contact us

Website: www.genobiotx.com
Email: info@genobiotx.com
Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA

    News Center

    2025.04.07

    Connect with GenoBioTX at AACR 2025

    We look forward to connecting with you at the upcoming AACR Annual Meeting in Chicago from April 25–30! At GenoBioTX, we understand that robust, translationally relevant preclinical models are critical for confident decision-making in oncology drug development. We specialize in developing genetically modified and humanized mouse models that provide the insights necessary to effectively evaluate […]

    2025.03.10

    Special Promotion: Humanized Models for Oncology Research (March–June)

    Accelerate your oncology research with GenoBioTX's humanized animal models. From March 1st to June 30th, we are offering a special promotion to support groundbreaking advancements in cancer research. Disease-Specific Humanized Models GenoBioTX provides a diverse range of humanized models tailored for high translational relevance across multiple disease areas, including: Oncology & Immuno-Oncology (Promotion Available) Tumor […]

    Email Back to top